Nanox to Host Business Update Video Presentation
Company to host webcast on Monday, August 16th at 8:30 am ETNEVE ILAN, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) --...
News
Allogene Therapeutics Receives FDA Orphan Drug Designation (ODD) for ALLO-715 for the Treatment of Multiple Myeloma (MM)
ODD Follows RMAT Designation Granted to ALLO-715 by the U.S. Food and Drug Administration in Multiple Myeloma PatientsPhase 1 Data...
MIMEDX Promotes Marion Snyder to Chief of Staff, Senior Vice President, Government Affairs
Promotion Recognizes Skilled Leadership and Contributions to MIMEDX’s Continued Growth MARIETTA, Ga., Aug. 12, 2021 (GLOBE NEWSWIRE) -- MiMedx Group,...
ABVC BioPharma Reports Second Quarter 2021 Results
Clinical Trials Continue Despite COVID-19 Restrictions Fremont, CA, Aug. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC Biopharma, Inc., a clinical...
Black Diamond Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Initial Phase 1 clinical PK, safety, and preliminary efficacy data for BDTX-189 presented at ASCO Annual Meeting; on track to...
Revive Confirms No Material Undisclosed Information
TORONTO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (Frankfurt:31R), a...
Metacrine Updates MET642 Clinical Development Milestone and Reports Second-Quarter 2021 Results
Interim data from the Phase 2a trial of MET642 in patients with NASH now expected early in the fourth quarter...
Fluo Labs Announces Partnership With a Leading Global Life Sciences Company
New Partnership will help Fluo Labs Bring to Market its Medical Device, Designed to Improve Hay Fever Symptoms via Light...
Junshi Biosciences and Coherus Announce U.S. FDA Breakthrough Therapy Designation Granted for Toripalimab for 1st Line Treatment of Nasopharyngeal Carcinoma
–1st line nasopharyngeal indication and 2nd/3rd line indications to be concurrently submitted 3Q 2021 in the toripalimab BLA–SHANGHAI, China, and REDWOOD CITY, Calif.,...
Junshi Biosciences and Coherus Announce U.S. FDA Breakthrough Therapy Designation Granted for Toripalimab for 1st Line Treatment of Nasopharyngeal Carcinoma
1st line nasopharyngeal indication and 2nd/3rd line indications to be concurrently submitted 3Q 2021 in the toripalimab BLASHANGHAI, China and...
Daré Bioscience Reports Second Quarter 2021 Financial Results and Provides a Company Update
Conference Call and Webcast Today at 4:30 p.m. Eastern TimeSAN DIEGO, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:...
Origin Therapeutics Closes $6.5 Million Private Placement to Fund New Investments in Psychedelics
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES VANCOUVER, British Columbia, Aug. 12, 2021...
Monopar Therapeutics Reports Second Quarter 2021 Financial Results and Recent Business Updates
Camsirubicin Phase 1b Clinical Trial Anticipated to Start in the U.S. in Q4 2021Validive® Phase 2b/3 VOICE Trial on Track...
Century Therapeutics Reports Second Quarter 2021 Financial Results and Business Updates
Continued Company investment across our iPSC platforms, programs, and manufacturingLead program, CNTY-101, remains on track for IND filing in mid-2022Recent...
R1 Announces Appointment of Agnes Bundy Scanlan to Board of Directors
MURRAY, Utah, Aug. 12, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that...
BioCardia Reports Second Quarter 2021 Financial Results and Business Highlights
SAN CARLOS, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- BioCardia, Inc. , a developer of cellular and cell-derived therapeutics for the...
F-star Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Company to Host Conference Call Today at 9 a.m. EDTCAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Aug. 12, 2021 (GLOBE NEWSWIRE)...
Selecta Biosciences Reports Second Quarter 2021 Financial Results and Provides Business Update
IND filing for wholly owned gene therapy program, SEL-302 (MMA-101, in combination with ImmTOR) in methylmalonic acidemia (MMA) expected during...
Healthwise and TCS Healthcare Technologies Join Forces to Achieve Better Health Outcomes
Partnership will reduce cost, ensure appropriate care, and help people better navigate their health care experiencesBOISE, Idaho, Aug. 12, 2021...
BiomX to Host Second Quarter 2021 Financial Results Conference Call and Webcast on August 16, 2021
NESS ZIONA, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage...
